0000950170-24-042033.txt : 20240404
0000950170-24-042033.hdr.sgml : 20240404
20240404210738
ACCESSION NUMBER: 0000950170-24-042033
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240325
FILED AS OF DATE: 20240404
DATE AS OF CHANGE: 20240404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cox John
CENTRAL INDEX KEY: 0001498428
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 24824533
MAIL ADDRESS:
STREET 1: C/O BIOVERATIV INC.
STREET 2: 225 SECOND AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dyne Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818794
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 364883909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1560 TRAPELO ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 786-8230
MAIL ADDRESS:
STREET 1: 1560 TRAPELO ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
3/A
1
ownership.xml
3/A
X0206
3/A
2024-03-25
2024-03-27
0
0001818794
Dyne Therapeutics, Inc.
DYN
0001498428
Cox John
1560 TRAPELO ROAD
WALTHAM
MA
02451
true
true
false
false
CEO & President
Common Stock
5000
D
This Form 3/A is being filed to correct the number of shares of common stock reported in Table I of the original Form 3 filed on March 27, 2024, which inadvertently reported 10,000 shares of common stock beneficially owned by the reporting person instead of the 5,000 shares reported herein.
/s/ Richard Scalzo, Attorney-in-Fact
2024-04-04